Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer
Recruiting · NCT06648148 · Observational (researchers observe without assigning treatment) · Lead sponsor: Institute of Oncology Ljubljana
View the official record on ClinicalTrials.gov →What this trial is about
The purpose of this study is to identify potential genetic and other molecular biomarkers of response to radiation therapy in breast cancer that may help to personalize breast cancer radiation treatment in the future.
Who can take part
Age range
18 Years to 75 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Breast cancer patients with DCIS with an indication for adjuvant radiation therapy
Exclusion criteria
- Any specific systemic oncological therapy
Where it is running
1 location listed.
- Institute of Oncology Ljubljana - Ljubljana, Slovenia